Lipotype GmbH Announces US Subsidiary, Lipotype Inc.

Lipotype provides lipidomics analysis services to pharmaceutical, medical, cosmetic, food industry companies and academic customers from universities and research institutions.
Lipotype provides lipidomics analysis services to pharmaceutical, medical, cosmetic, food industry companies and academic customers from universities and research institutions.

Lipotype GmbH has announced the launch of U.S. subsidiary, Lipotype Inc. With about 40% of Lipotype’s customers based in the U.S., the expansion will allow Lipotype’s team to provide local support.

Related: Unilever Ventures Invests $2M in Straand Prebiotic Scalp Care

Lipotype provides lipidomics analysis services to pharmaceutical, medical, cosmetic, food industry companies and academic customers from universities and research institutions. This team helps R&D facilities and labs to understand the complexity of lipid metabolism without committing to significant investments in instruments and specialist training, per Lipotype.  

Lipotype’s mass spectrometry-based platform can be applied to analysis of biological samples and covers the analysis of more than 4200 lipids. 

Oliver Uecke, Ph.D., CEO of Lipotype Inc., commented: “Thanks to all the trust and support our customers have been giving us, we have been able to better understand our customers’ needs and their projects. And the establishment of a U.S. subsidiary is a commitment from our side promising to serve them better.”

John Bajor, Unilever, commented: “Lipotype provides us with consistent and reliable service in the area of lipidomic sample analysis. Therefore, Lipotype establishing a U.S. subsidiary, geographically near our labs will certainly help us continue such endeavours."

More in Regulatory & Research